1. Home
  2. ANET vs MRK Comparison

ANET vs MRK Comparison

Compare ANET & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arista Networks Inc.

ANET

Arista Networks Inc.

HOLD

Current Price

$138.92

Market Cap

173.1B

ML Signal

HOLD

Logo Merck & Company Inc. (new)

MRK

Merck & Company Inc. (new)

HOLD

Current Price

$116.14

Market Cap

268.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANET
MRK
Founded
2004
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
173.1B
268.7B
IPO Year
2014
1994

Fundamental Metrics

Financial Performance
Metric
ANET
MRK
Price
$138.92
$116.14
Analyst Decision
Strong Buy
Buy
Analyst Count
15
14
Target Price
$173.80
$123.21
AVG Volume (30 Days)
7.7M
10.1M
Earning Date
05-14-2026
05-05-2026
Dividend Yield
N/A
2.83%
EPS Growth
23.32
8.01
EPS
2.75
7.28
Revenue
$9,005,700,000.00
$65,011,000,000.00
Revenue This Year
$28.79
$3.74
Revenue Next Year
$21.10
$5.47
P/E Ratio
$49.14
$16.58
Revenue Growth
28.60
1.31
52 Week Low
$59.43
$75.40
52 Week High
$164.94
$125.14

Technical Indicators

Market Signals
Indicator
ANET
MRK
Relative Strength Index (RSI) 54.74 45.37
Support Level $138.18 $105.23
Resistance Level $139.93 $125.14
Average True Range (ATR) 5.66 2.77
MACD -0.09 -0.99
Stochastic Oscillator 64.43 14.36

Price Performance

Historical Comparison
ANET
MRK

About ANET Arista Networks Inc.

Arista Networks is a networking equipment provider that mainly sells Ethernet switches and software to data centers. Its marquee product is its extensible operating system, or EOS, that runs a single image across every single one of its devices. The firm operates as one reportable segment. It has steadily gained market share since its founding in 2004, with a focus on high-speed applications. Arista counts Microsoft and Meta Platforms as its largest customers and derives roughly three-quarters of its sales from North America.

About MRK Merck & Company Inc. (new)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Share on Social Networks: